Gilder Gagnon Howe & CO LLC Seres Therapeutics, Inc. Transaction History

Gilder Gagnon Howe & CO LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$6.02 - $11.43 $20,347 - $38,633	-3,380 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.46 - $22.6 $13.1 Million - $54.3 Million	-2,403,505 Reduced 99.86%	3,380 $24,000
Q2 2021 Aug 16, 2021	SELL	$18.46 - $24.36 $3.72 Million - $4.9 Million	-201,270 Reduced 7.72%	2,406,885 $57.4 Million
Q1 2021 May 17, 2021	SELL	$17.66 - $28.92 $10.2 Million - $16.7 Million	-575,819 Reduced 18.08%	2,608,155 $53.7 Million
Q4 2020 Feb 16, 2021	SELL	$23.25 - $37.73 $33,619 - $54,557	-1,446 Reduced 0.05%	3,183,974 $78 Million

Q3 2020 Nov 16, 2020	BUY	$3.74 - $28.74 $11.5 Million - $88.6 Million	3,081,867 Added 2976.13%	3,185,420 $90.2 Million
Q2 2020 Aug 14, 2020	SELL	$3.04 - $6.2 $2,176 - $4,439	-716 Reduced 0.69%	103,553 $493,000
Q1 2020 May 15, 2020	BUY	$2.64 - $3.82 $275,270 - $398,307	104,269 New	104,269 $372,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $86.9M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Gilder Gagnon Howe & CO LLC, based on Form 13F filings with the SEC.

Stay updated on Gilder Gagnon Howe & CO LLC with notifications on news.